Michael K. Smith

Statistical Issues in Drug Research and Development.

Michael K. Smith, Karl E. Peace · Journal of the Royal Statistical Society Series C (Applied Statistics) · 1991 · 86 citations

Pharmacy, Biostatistics, Pharmacology +9

Simulation-based sequential Bayesian design

Peter Müller, Don Berry, Michael K. Smith et al. · Journal of Statistical Planning and Inference · 2007 · 77 citations

Computing, Biostatistics, Computer Science +12

The effects of ketoconazole on ziprasidone pharmacokinetics —a placebo‐controlled crossover study in healthy volunteers

J. Miceli, Michael K. Smith, L. Robarge et al. · British Journal of Clinical Pharmacology · 2000 · 73 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +9

Implementation of a Bayesian adaptive design in a proof of concept study

Michael K. Smith, Ieuan Jones, Mark Morris et al. · Pharmaceutical Statistics · 2006 · 53 citations

Medicine, Pharmacoeconomics, Pharmacology +16

VANTAGE 014: Vorinostat (V) in Patients With Advanced Malignant Pleural Mesothelioma (MPM) who Have Failed Prior Pemetrexed and Either Cisplatin or Carboplatin Therapy: A Phase III, Randomized, Double-Blind, Placebo-Controlled Trial

Lee M. Krug, Hedy L. Kindler, Hilary Calvert et al. · European Journal of Cancer · 2011 · 32 citations

Medicine, Oncology, Pharmacotherapy +12